Related articles:

Cancer Genetics Inc.: Precision Oncology Diagnostics Leader, Cancer Genetics, Inc. & Precision Therapeutics Company, Lantern Pharma, Inc. Announce Strategic Collaboration Focused on Drug Rescue & Repurposing Leveraging Genomics, Biomarkers & Artificial Intelligence Driven Development for Multiple Lead Oncology Compounds
January 17, 2017
January 17, 2017

Cancer Genetics Inc.: Cancer Genetics, Inc. and ApoCell Announce Partnership Focused on Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform for Rare Cell Capture and Detection
September 26, 2016
September 26, 2016

Cancer Genetics Inc.: Cancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive Clinical Trial and Companion Diagnostic Solutions for the Oncology Industry
September 20, 2016
September 20, 2016

Cancer Genetics Inc.: Cancer Genetics to Report Third Quarter Financial Results on Tuesday, November 10, 2015
November 03, 2015
November 3, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Receives Third Patent for Proprietary Genomic FHACT(R) Test, Further Advancing the Detection and Treatment of Cervical and Other HPV-Associated Cancers
October 28, 2015
October 28, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Finalizes Purchase of Los Angeles-based Molecular Profiling Laboratory, Response Genetics, Inc., Adding $10-$12M in Annual Revenue and Establishing a National Clinical Sales Footprint
October 12, 2015
October 12, 2015

Cancer Genetics Inc.: Cancer Genetics Receives Bankruptcy Court Approval to Purchase Los Angeles-Based Response Genetics, Inc.
October 02, 2015
October 2, 2015

Cancer Genetics Inc.: Cancer Genetics Announces Strong First Quarter 2015 Results
May 12, 2015
May 12, 2015

Cancer Genetics Inc.: Cancer Genetics Enters Into Multi-Year Research Collaboration With Moffitt Cancer Center for Genomics-Based Prediction of Side Effects Associated With Chemotherapy
May 06, 2015
May 6, 2015

Cancer Genetics Inc.: Cancer Genetics to Report First Quarter Financial Results on Tuesday, May 12
May 05, 2015
May 5, 2015

Cancer Genetics Inc.: Cancer Genetics Announces Record Fourth Quarter and Full-Year 2014 Revenue
March 12, 2015
March 12, 2015

Cancer Genetics Inc.: Cancer Genetics to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Thursday, March 12
February 26, 2015
February 26, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Launches Digital Platform to Enable Collaboration With Community Hospitals and Laboratories
January 20, 2015
January 20, 2015

Cancer Genetics Inc.: Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors
December 16, 2014
December 16, 2014

Cancer Genetics Inc.: Cancer Genetics, Inc. Strengthens Clinical Trials Leadership Team With Hire of Rob Fannon as Vice President of Operations
December 10, 2014
December 10, 2014

Cancer Genetics Inc.: Cancer Genetics Inc. Announces the Appointments of Dr. Howard McLeod and Geoffrey Harris to Its Board of Directors
December 03, 2014
December 3, 2014

Cancer Genetics Inc.: Cancer Genetics Inc Receives Second Patent for Genomic Cervical Cancer Test; Strengthens Position of FHACT®
November 11, 2014
November 11, 2014

Cancer Genetics Inc.: Cancer Genetics Inc Receives Second Patent for Genomic Cervical Cancer Test; Strengthens Position of FHACT(R)
November 11, 2014

Cancer Genetics Inc.: Cancer Genetics Announces Strong Third Quarter With Growth Across All Categories
November 10, 2014
November 10, 2014

Cancer Genetics Inc.: Cancer Genetics, Inc. to Report Third Quarter 2014 Financial Results on Monday, November 10
October 30, 2014
October 30, 2014

Cancer Genetics Inc.: Cancer Genetics Inc. Granted Patent for Genomic Probe Set Used in Proprietary Test for Cervical and Other HPV-Associated Cancers
October 21, 2014
October 21, 2014

Cancer Genetics Inc.: Cancer Genetics Inc. Announces Collaboration With Leading Oncology Researchers at Columbia University to Identify Genomic Signatures, Biomarkers and Novel Treatments for MDS and AML
October 13, 2014
October 13, 2014

Cancer Genetics Inc.: Cancer Genetics, Inc. and Beth Israel Deaconess Medical Center Enter Into Collaboration to Correlate Genomic Profiles to Patient Outcome in Diffuse Large B-Cell Lymphoma
September 23, 2014
September 23, 2014

Pin It on Pinterest

Share This